Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic

Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic

Background: The COVID-19 pandemic brought unprecedented global disruption to both healthcare providers and patients with respiratory allergies. There are limited real-life data on the impact of the COVID-19 pandemic on the risk perception of patients with allergy treated with allergen immunotherapy...

Full description

Bibliographic Details
Main Authors: Philippe Devillier, MD, PhD, Sarah Saf, MD, Christine Rolland, BA, Giorgio Walter Canonica, MD, Pascal Demoly, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:World Allergy Organization Journal
Subjects:
COVID-19
Allergen immunotherapy
Respiratory allergy
Allergic rhinitis
Asthma
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455124000334

Internet

http://www.sciencedirect.com/science/article/pii/S1939455124000334

Similar Items